EXPO 📈 Exponent - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US30214U1025

EXPO: Consulting, Engineering, Science, Environmental, Health, Services

Exponent, Inc. is a multifaceted science and engineering consulting firm with a global presence, operating in the United States and internationally. The company's services are divided into two primary segments: Engineering and Other Scientific, and Environmental and Health. This structural division enables Exponent to provide specialized expertise across a broad spectrum of disciplines, catering to the complex needs of its diverse client base.

The Engineering and Other Scientific segment is a hub for interdisciplinary services, encompassing areas such as biomechanics, biomedical engineering, and data sciences, among others. This segment is designed to tackle intricate challenges that require a deep understanding of both theoretical and practical aspects of engineering and science. By integrating insights from electrical engineering, computer science, and materials science, Exponent's team can offer comprehensive solutions to problems that span multiple fields of expertise.

In contrast, the Environmental and Health segment focuses on issues related to ecological and biological sciences, environmental and earth sciences, and health sciences. This includes services such as chemical regulation and food safety, reflecting the company's commitment to addressing critical environmental and health challenges. By providing expert analysis and consulting services in these areas, Exponent helps its clients navigate complex regulatory landscapes and mitigate potential risks to human health and the environment.

With a portfolio of approximately 90 technical disciplines, Exponent is well-equipped to solve a wide range of pressing and complicated challenges facing its stakeholders. The company's client base is equally diverse, spanning sectors such as chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other key areas of the economy. This breadth of expertise and client reach underscores Exponent's position as a leading science and engineering consulting firm.

Founded in 1967 and headquartered in Menlo Park, California, Exponent has a long history of providing high-quality consulting services. Initially known as The Failure Group, Inc., the company underwent a name change to Exponent, Inc. in 1998, reflecting its evolving scope and mission. Today, Exponent continues to operate as a common stock company, listed under the ISIN US30214U1025, and is classified under the GICS Sub Industry of Research & Consulting Services. More information about the company can be found at its official website: https://www.exponent.com.

Additional Sources for EXPO Stock

EXPO Stock Overview

Market Cap in USD 5,011m
Sector Industrials
Industry Engineering & Construction
GiC Sub-Industry Research & Consulting Services
IPO / Inception 1990-08-17

EXPO Stock Ratings

Growth 5y 37.9%
Fundamental 78.6%
Dividend 64.0%
Rel. Strength Industry -64.5
Analysts 3.67/5
Fair Price Momentum 78.70 USD
Fair Price DCF 78.24 USD

EXPO Dividends

Dividend Yield 12m 1.24%
Yield on Cost 5y 1.69%
Annual Growth 5y 10.20%
Payout Consistency 100.0%

EXPO Growth Ratios

Growth Correlation 3m -83.7%
Growth Correlation 12m 76.4%
Growth Correlation 5y 43%
CAGR 5y 6.46%
CAGR/Mean DD 5y 0.39
Sharpe Ratio 12m 0.13
Alpha -22.07
Beta 0.96
Volatility 29.63%
Current Volume 640.7k
Average Volume 20d 253.3k
What is the price of EXPO stocks?
As of December 21, 2024, the stock is trading at USD 90.67 with a total of 640,674 shares traded.
Over the past week, the price has changed by -2.67%, over one month by -4.33%, over three months by -17.91% and over the past year by +7.55%.
Is Exponent a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Exponent (NASDAQ:EXPO) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 78.62 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EXPO as of December 2024 is 78.70. This means that EXPO is currently overvalued and has a potential downside of -13.2%.
Is EXPO a buy, sell or hold?
Exponent has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold EXPO.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for EXPO stock price target?
According to ValueRays Forecast Model, EXPO Exponent will be worth about 87.3 in December 2025. The stock is currently trading at 90.67. This means that the stock has a potential downside of -3.72%.
Issuer Forecast Upside
Wallstreet Target Price 116 27.9%
Analysts Target Price 103.5 14.2%
ValueRay Target Price 87.3 -3.7%